Avance Biosciences is thrilled to announce its participation in the highly anticipated World Vaccine Congress 2025, taking place from April 21-24, 2025. This prestigious event brings together vaccine industry leaders, researchers, and innovators to discuss the latest breakthroughs and advancements in vaccine development, manufacturing, and distribution. As a trusted provider of GLP & GMP-compliant biological assay development, validation, and testing services, Avance Biosciences is excited to present its cutting-edge solutions to help advance vaccine science.
-
Bioanalytics: Offering method development, assay validation, and testing services tailored for vaccine research and development.
-
Preclinical Studies: Providing safety and efficacy testing using GLP-compliant methodologies for vaccine candidates.
-
Clinical Studies: Supporting vaccine clinical trials with bioanalytical assay development to ensure precision and regulatory compliance.
-
Manufacturing and Analytical Characterization: Conducting quality control testing for vaccines, including potency, stability, and identity assessments to ensure safety and effectiveness.
Attendees of the World Vaccine Congress 2025 will have the opportunity to connect with Avance Biosciences’ experienced team, who will be on hand to discuss the latest in vaccine testing and explore collaboration opportunities. Our team will provide valuable insights into our advanced solutions, demonstrate how we can support vaccine development projects, and address the challenges involved in ensuring vaccine safety, efficacy, and regulatory compliance.
We invite all conference participants to visit our booth to learn more about how Avance Biosciences is contributing to the global vaccine development landscape. Join us as we connect with industry leaders, foster new collaborations, and drive forward the future of vaccine science at this vital event.
See you at World Vaccine Congress – 2025!
Accelerate your drug development with Avance Biosciences’ Next-Generation Sequencing (NGS) Center of Excellence, delivering GMP- and GLP-compliant genomics solutions to power your development programs. Our capabilities include Short-read Next-gen Sequencing, Nanopore Third-gen Sequencing, PacBio Third-gen Sequencing, 10X Chromium Single-cell Sequencing, and Mission Bio Tapestri Single-cell Sequencing. Learn more at our NGS Center of Excellence and contact our experts to get started.
